BPC-157 / TB-500
≥99% HPLC verified · 2 sizes available
Combination of BPC-157 and TB-500 in matched concentrations for paired pathway research.
Size
What research has shown
Synthetic compound
Defined synthetic material for controlled laboratory research and analytical method development.
In the literature
Cited across published research on peptide stability, receptor interaction, and biological signaling.
Lab settings
Examined in vitro and in preclinical models. Studies focus on molecular properties under controlled systems.
Non-therapeutic
For laboratory research only. Not approved for human consumption, treatment, or therapeutic application.
About this compound
A pre-blended formulation of BPC-157 and TB-500 supplied in a single vial for research applications studying both compounds in parallel. The blend is referenced in research literature on paired tissue-pathway and angiogenic-pathway investigation, where both compounds are commonly co-referenced.
Each blend lot is independently HPLC-verified for both peptides separately, with a combined Certificate of Analysis documenting each component's identity, purity, and concentration. The COA is published on this page before the lot ships.
This material is supplied for in vitro research only. It is not a drug, supplement, food, or cosmetic, and is not for human or veterinary consumption.
This material is supplied for in vitro research only. It is not a drug, supplement, food, or cosmetic, and is not for human or veterinary consumption.
Specifications
| Form | Lyophilized powder (combined) |
| Purity | ≥99% (HPLC, each peptide independently) |
| Size | 10MG |
| Vial | 3ML |
| Storage | -20°C, desiccated, protected from light |
| Origin | USA |
| Identity | Mass spectrometry (each peptide independently) |
Reconstitution, storage, and handling are the responsibility of the qualified researcher.Perplexa Labs does not provide protocols, dosing guidance, or human-use instructions.